Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

Is Wall Street Bullish or Bearish on Bristol-Myers Stock?

Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) is a leading biopharmaceutical company that discovers, develops, licenses, manufactures, markets, and sells innovative medicines across several therapeutic areas. Valued at a market cap of $93.6 billion, the company offers products for oncology, haematology, immunology, cardiovascular, and neuroscience, among others. 

This healthcare giant has lagged behind the broader market over the past 52 weeks. Shares of BMY have declined 6.3% over this time frame, while the broader S&P 500 Index ($SPX) has soared 17%. Moreover, on a YTD basis, the stock is down 18.7%, compared to SPX’s 8.2% gain. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.